Agenus Expands Clinical Momentum with Three BOT+BAL Studies Accepted for ESMO 2026
Market Chameleon (Mon, 20-Jul 9:18 AM)
Agenus Secures Up to $340 Million in Oversubscribed Private Placement to Fund Game-Changing Colon Cancer Trial
Market Chameleon (Mon, 13-Jul 9:52 AM)
Agenus Secures Up To $340 Million Funding to Back Phase 3 BOT+BAL Trial in MSS Colon Cancer—Premium Warrant Pricing Highlights Investor Confidence
Market Chameleon (Mon, 13-Jul 7:27 AM)
